Imperial infection team wins GSK challenge to develop medicines of the future
Professor Sriskandan and Dr Pease have together been selected as one of two winners of GSK's 2016 UK Golden Triangle Discovery Fast Track Challenge.
Major new appetite regulator successfully altered in mice
An Imperial study has found a new link between certain brain receptors and obesity in mice, giving a possible new drug target for appetite regulation.
Imperial students collaborate on drug discovery for neglected diseases
Chemistry students are making compounds that may help treat diseases thanks to an open collaboration with the Drugs for Neglected Diseases initiative.
Window to brain's reward system could lead to better treatments for alcoholism
Scanning the brains of alcoholics taking medication to beat their addiction has revealed new insights into how the treatments work.
New 'gene silencer' drug injections reduce cholesterol by 50% in clinical trial
The first in a new class of gene-silencing drugs, known as inclisiran, has halved cholesterol levels in patients at risk of cardiovascular disease.
6
Stopping kidney stones in their tracks
In the latest IMSE Highlight Seminar, Prof Michael Ward (New York University) presented recent work on a potential new treatment for kidney stones.
Mapping signal paths in proteins could reveal new direction for drug development
Using maths previously applied to traffic jams and electrical grids, researchers have developed a new method to map signal propagation in proteins.
Video
Steps that lead to genes being switched on revealed in atomic simulation
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
1
Malaria scientists aim to look 'under the bonnet' of the parasite with new grant
A research team has received $1.45 million to investigate how malaria parasites move, with the aim of developing new drugs to combat the disease.
3
World Cancer Day 2016: a year of cancer research at Imperial College London
Look back at Imperial's work to prevent and fight cancer over the past 12 months.
